MethodHub Partners with Datafoundry to Modernize AI-Driven Pharmacovigilance and Pharma-Tech Offerings

MethodHub Partners with Datafoundry to Modernize AI-Driven Pharmacovigilance and Pharma-Tech Offerings​

Methodhub Software Limited, a global AI-centric technology services company, has announced a strategic partnership with Datafoundry, a leading provider of purpose-built AI/ML SaaS solutions for pharmacovigilance (PV) and life sciences. This collaboration aims to deliver end-to-end, technology-led PV and pharma-tech solutions to pharmaceutical, biotech, and life sciences enterprises worldwide.

The industry is undergoing rapid transformation driven by evolving regulatory intensity and digital advancements. For highly regulated sectors like pharmaceuticals, maintaining compliance requires embracing Industry 4.0 principles, which mandate the integration of intelligent systems and data-driven insights.

MethodHub will bring its established capabilities in PV operations, regulatory compliance, and global delivery to this partnership. Datafoundry, specializing in AI/ML SaaS solutions, will contribute advanced tools designed for safety enhancement. These capabilities include:

• Safety AI: End-to-end safety case management supported by intelligent automation, covering intake, triage, and compliance monitoring.
• Signal AI: AI-driven detection of safety signals and risk management, helping reduce false positives.
• Literature Monitor: Automated global literature surveillance featuring AI-driven screening and multilingual support.

This combined offering enables organizations to transition from fragmented, manual PV processes to scalable, intelligent, automated safety operations, ensuring compliance with standards such as FDA and EMA guidelines.

Mr. Ahobilam, CEO and Executive Director of MethodHub Software Limited, stated that in the pharmaceutical industry, "Pharmacovigilance is no longer a back-office compliance function; it is central to patient safety and brand trust." He added that by combining cutting-edge AI platforms with domain expertise, the partnership helps clients build future-ready, intelligent PV ecosystems.

In addition to this collaboration, MethodHub also utilizes its proprietary AI-powered full-time hiring platform, QuantumHire, which supports clients in efficiently scaling specialized Pharmacovigilance talent and strengthening high-quality PV teams during technology transformation initiatives.

MethodHub currently serves over 40 global clients with a team exceeding 500 professionals across key international markets including the USA, India, Canada, and Thailand. The company maintains a strong focus on quality and compliance, backed by certifications such as ISO 27001, ISO 9001, SOC 2 Type II, and HIPAA HITECH.

Datafoundry is an AI/ML-focused SaaS provider whose purpose-built platforms help enterprises achieve faster processing, improved accuracy, and global regulatory compliance at scale through automated safety case management and literature surveillance.

Stock Price Movement​

As of 12:29, Methodhub Software Ltd shares are ticking up at ₹86.36, following a strong gain of 3.92%. The stock has seen movement during the day between an intraday low of ₹84.58 and a high of ₹87.19.